Delivery Order SPE2DB20D3111-SPE2DB25FA8YM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,041.04 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 30, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,143.52 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL dosage). This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,504.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pen injectors on July 22, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen injectors valued at $4,833.42, with an ultimate completion date of August 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $4,413.01 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 11, 2025, with completion scheduled for August 12, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within the pharmaceutical distribution portfolio that AmerisourceBergen...
- The Defense Logistics Agency awarded a $3,453.76 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) with an ultimate completion date of July 31, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors, valued at $2,775.42 with a firm fixed price. The award was made on July 29, 2025, with an ultimate completion date of July 30, 2025, and represents a non-set-aside, competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,408.41 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pen injectors on a firm fixed-price basis. This non-set-aside award was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical delivery. The order represents a single transaction within the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pen injectors with a firm fixed price ceiling value of $2,644.53 and an ultimate completion date of July 22, 2025. This is a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle running through December 2026 that supports global...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA8YMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pen injectors, valued at $1,201.20 with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a primary pharmaceutical distributor for federal medical procurement. This delivery order reflects AmerisourceBergen's critical role within the DLA Medical Supply Chain, supporting military healthcare programs and related federal health systems. The award demonstrates the contractor's capability to fulfill federal pharmaceutical needs through open competition, consistent with DLA's strategy of leveraging prime vendor contracts for comprehensive pharmaceutical support. Trulicity, a diabetes management medication, aligns with AmerisourceBergen's extensive portfolio of specialty medications and brand-name drugs supplied to military and veteran healthcare systems under its overarching prime vendor agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/18/25 |